Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy. - Xiang Y; Xu J; McGovern BL; Ranzenigo A; Huang W; Sang Z; Shen J; Diaz-Tapia R; Pham ND; Teunissen AJP; Rodriguez ML; Benjamin J; et al. (Cell, 2024)